thyroxine has been researched along with Carcinoma, Anaplastic in 181 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate if a supervised exercise training program improves the quality of life (QoL) of differentiated thyroid carcinoma (DTC) patients on TSH-suppressive therapy with levothyroxine (L-T4)." | 9.19 | Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. ( Chachamovitz, DS; Rocque, Mde L; Santos, ML; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2014) |
| "We measured serum thyroxine (T4), free T4, 3,5,3-triiodothyronine (T3), free T3, reverse T3 (rT3), and TSH concentrations at baseline and after 26 wk in 21 patients with progressive nonmedullary thyroid carcinoma treated with sorafenib." | 9.14 | Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. ( Abdulrahman, RM; Corssmit, EP; Gelderblom, H; Hoftijzer, H; Hovens, GC; Kapiteijn, E; Pereira, AM; Reiners, C; Romijn, JA; Smit, JW; Verburg, E; Verloop, H; Visser, TJ, 2010) |
| " The aim of the present study was to estimate the influence of L-thyroxine (L-T4) administration on poor-platelet plasma (P-PP) VEGF concentrations in patients with induced short-term hypothyroidism, monitored for differentiated thyroid carcinoma." | 9.12 | Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma. ( Adamczewski, Z; Brzeziński, J; Dedecjus, M; Kołomecki, K; Lewiński, A; Tazbir, J, 2007) |
| "The effect of subclinical hyperthyroidism on bone mineral density is controversial and could be significant in patients with differentiated thyroid carcinoma who receive suppressive doses of levothyroxine (LT4)." | 9.11 | Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. ( Alonso, N; Granada, ML; Holgado, S; Reverter, JL; Salinas, I; Sanmartí, A, 2005) |
| "The patient developed Graves' disease after lenvatinib treatment for radioactive iodine refracted thyroid follicular carcinoma." | 8.12 | Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. ( Iwasaki, H; Kadoya, M; Matsui, A; Murayama, D; Toda, S, 2022) |
| "Studies on the effect of exogenous subclinical thyrotoxicosis on bone mineral density (BMD) in male patients treated with suppressive doses of levothyroxine for differentiated thyroid carcinoma (DTC) are not conclusive." | 7.76 | Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. ( Aguilera, E; Colomé, E; Holgado, S; Mateo, L; Reverter, JL; Sanmartí, A; Soldevila, B, 2010) |
| "The aim of our study was to evaluate the acute effect of the recombinant human TSH (rhTSH)-induced TSH surge on serum leptin levels in thyroidectomized patients undergoing levothyroxine (L-T4) suppressive therapy for differentiated thyroid carcinoma (DTC)." | 7.74 | Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing. ( Andraghetti, G; Briatore, L; Cavallero, D; Cecoli, F; Ghiara, C; Giusti, M; Minuto, F; Mussap, M, 2008) |
| "Patients with differentiated thyroid carcinoma (DTC) must receive suppressive levothyroxine (LT(4)) therapy for the rest of their lives." | 7.72 | Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment. ( Gallowitsch, HJ; Jauk, B; Jost, R; Kresnik, E; Leb, G; Lind, P; Mikosch, P; Obermayer-Pietsch, B, 2003) |
| "Life-time L-thyroxine therapy is obligatory in patients treated for differentiated thyroid carcinoma (DTC) in order to suppress serum TSH." | 7.71 | [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression]. ( Czernik, E; Gubała, E; Jarzab, B; Jurecka-Tuleja, B; Kowalczyk, P; Roskosz, J, 2001) |
| "To determine bone mineral density in patients with differentiated thyroid carcinoma receiving thyroxine replacement therapy in suppressive doses, we studied 65 patients (47 women and 18 men; age 25-83 years, mean+/-SD 52." | 7.69 | Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma. ( Görres, G; Götze, M; Kaim, A; Müller-Brand, J; Otte, A, 1996) |
| "A comparative analysis of triiodothyronine (T3) and thyroxine (T4) distribution in organs and tissues of tumour-bearing and intact mice conducted wih 125J labelled T3 and T4 has shown considerable differences in the accumulation character of these hormones in mice with Lewis carcinoma and in intact animals in the liver, kidneys, lungs, adrenal glands, lymphatic nodes." | 7.67 | [Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma]. ( Dedenkov, AN; Norets, TA; Petrova, GA; Smoryzanova, OA; Vereshchagina, GV, 1985) |
| "Forty patients with thyroid cancer submitted to thyroidectomy, who received 3." | 6.82 | Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants). ( Batista, KC; Calsolari, MR; Rosário, PW, 2016) |
| "To evaluate if a supervised exercise training program improves the quality of life (QoL) of differentiated thyroid carcinoma (DTC) patients on TSH-suppressive therapy with levothyroxine (L-T4)." | 5.19 | Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. ( Chachamovitz, DS; Rocque, Mde L; Santos, ML; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2014) |
| "We measured serum thyroxine (T4), free T4, 3,5,3-triiodothyronine (T3), free T3, reverse T3 (rT3), and TSH concentrations at baseline and after 26 wk in 21 patients with progressive nonmedullary thyroid carcinoma treated with sorafenib." | 5.14 | Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. ( Abdulrahman, RM; Corssmit, EP; Gelderblom, H; Hoftijzer, H; Hovens, GC; Kapiteijn, E; Pereira, AM; Reiners, C; Romijn, JA; Smit, JW; Verburg, E; Verloop, H; Visser, TJ, 2010) |
| "Twenty-five subjects with a history of differentiated thyroid carcinoma with > 10 years TSH-suppressive therapy with l-thyroxine completed the study." | 5.12 | Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial. ( Corssmit, EP; Eustatia-Rutten, CF; Frölich, M; Heemstra, KA; Heijboer, AC; Romijn, JA; Smit, JW, 2006) |
| " The aim of the present study was to estimate the influence of L-thyroxine (L-T4) administration on poor-platelet plasma (P-PP) VEGF concentrations in patients with induced short-term hypothyroidism, monitored for differentiated thyroid carcinoma." | 5.12 | Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma. ( Adamczewski, Z; Brzeziński, J; Dedecjus, M; Kołomecki, K; Lewiński, A; Tazbir, J, 2007) |
| "The effect of subclinical hyperthyroidism on bone mineral density is controversial and could be significant in patients with differentiated thyroid carcinoma who receive suppressive doses of levothyroxine (LT4)." | 5.11 | Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. ( Alonso, N; Granada, ML; Holgado, S; Reverter, JL; Salinas, I; Sanmartí, A, 2005) |
| " Recombinant TSH is comparable to hypothyroidism in the generation of Tg and in the execution of iodine-131 whole-body scanning, with the advantage of sparing patients from the symptoms of hypothyroidism and from impaired quality of life induced by levothyroxine withdrawal, in addition to a reduced exposure to elevated TSH and shorter absence from work, with recombinant TSH being the preparation indicated for the diagnosis of metastases in both low risk (Tg after recombinant TSH) and moderate or high risk patients (Tg and iodine-131 scanning after recombinant TSH)." | 4.82 | [Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma]. ( Barroso, AL; Fagundes, TA; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW, 2005) |
| "The patient developed Graves' disease after lenvatinib treatment for radioactive iodine refracted thyroid follicular carcinoma." | 4.12 | Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. ( Iwasaki, H; Kadoya, M; Matsui, A; Murayama, D; Toda, S, 2022) |
| "A prospective cohort study was conducted, in which, patients with differentiated thyroid carcinoma and benign thyroid nodules were given oral L-T4 therapy after surgery, after meeting the criteria of TSH suppression therapy and thyroxine replacement therapy, respectively, the patients were continually given L-T4 therapy for 6 and 12 months, and then, the neuropsychological test was performed." | 3.91 | Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study. ( Ai, JW; Bai, Y; Bao, W; Jin, S; Liu, Y; Yang, YT; Yong, H, 2019) |
| " These assessments were analyzed against perioperative measurements to determine if any of these preoperative values were predictive of postoperative hypothyroidism and the need for postoperative levothyroxine treatment." | 3.81 | Prediction of thyroid hormone supplementation after thyroid lobectomy. ( Ahn, SH; Jeong, WJ; Lee, DY; Seok, J, 2015) |
| " We report a patient with papillary thyroid carcinoma who were under treatment with levothyroxine and experienced an elevated TSH level by ingestion of Carum carvi." | 3.81 | Carum induced hypothyroidism: an interesting observation and an experiment. ( Ayati, N; Naghibi, SM; Ramezani, M; Zakavi, SR, 2015) |
| "Thyroxine (T4) requirement after total thyroidectomy for differentiated thyroid carcinoma (DTC) is a debated issue." | 3.81 | Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study. ( Brusca, N; Cellini, M; Centanni, M; Del Duca, SC; Frattaroli, FM; Gargano, L; Gatto, I; Santaguida, MG; Verga Falzacappa, C; Virili, C, 2015) |
| "Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
| "A cross-sectional study was carried out with 29 patients on TSH-suppressive therapy with levothyroxine for thyroid carcinoma and 35 euthyroid subjects." | 3.77 | Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism. ( Chachamovitz, DS; Oliveira, FP; Santos, MA; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2011) |
| "Studies on the effect of exogenous subclinical thyrotoxicosis on bone mineral density (BMD) in male patients treated with suppressive doses of levothyroxine for differentiated thyroid carcinoma (DTC) are not conclusive." | 3.76 | Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. ( Aguilera, E; Colomé, E; Holgado, S; Mateo, L; Reverter, JL; Sanmartí, A; Soldevila, B, 2010) |
| "We studied 11 patients, previously treated with thyroidectomy for differentiated thyroid carcinoma, during hypothyroidism caused by cessation of thyroxine substitution for 4 weeks and during thyroxine replacement therapy, and 21 matched healthy controls." | 3.76 | Short-term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized differentiated thyroid carcinoma patients. ( Burggraaf, J; Corssmit, EP; Heemstra, KA; Romijn, JA; Smit, JW; van der Klaauw, AA, 2010) |
| " The aim of this study was to evaluate the effect of antibone resorptive agents, in particular alendronate (ALN) on BMD in postmenopausal osteoporotic women with thyroid carcinoma who were receiving long-term thyrotropin (TSH)-suppressive therapy with thyroxine." | 3.75 | Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. ( Assante, R; Fonderico, F; Lupoli, G; Lupoli, GA; Marciello, F; Martinelli, A; Panico, A, 2009) |
| " Here we report an unusual case with radiation-induced hypothyroidism who had undergone hemithyroidectomy for adenomatous goiter 8 years before the radiotherapy for nasopharyngeal cancer and subclinical hyperthyroidism due to Graves' disease developed during thyroxine replacement therapy." | 3.74 | Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Ozaki, H; Yoshida, K, 2007) |
| "The aim of our study was to evaluate the acute effect of the recombinant human TSH (rhTSH)-induced TSH surge on serum leptin levels in thyroidectomized patients undergoing levothyroxine (L-T4) suppressive therapy for differentiated thyroid carcinoma (DTC)." | 3.74 | Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing. ( Andraghetti, G; Briatore, L; Cavallero, D; Cecoli, F; Ghiara, C; Giusti, M; Minuto, F; Mussap, M, 2008) |
| "Thyroxine (T4) withdrawal or recombinant TSH is used for the stimulation of thyroglobulin (Tg), whole-body scanning (WBS) and iodine-131 treatment in patients with thyroid carcinoma." | 3.73 | Managing thyroid cancer without thyroxine withdrawal. ( Barroso, AL; Cardoso, LD; Guimarães, VC; Lauria, MW; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW; Vasconcelos, FP, 2006) |
| " Leukocytosis, hypoalbuminemia and hypothyroxinemia indicated poor prognosis." | 3.73 | Prognostic factors of anaplastic thyroid carcinoma. ( Jiang, JY; Tseng, FY, 2006) |
| "To compare bone mineral density (BMD) of lumbar spines (LS) and femoral neck (FN) by Dual energy X-ray absorptiometry (DEXA) in premenopausal well-differentiated thyroid carcinoma women S/P total or near total thyroidectomy with a control group and the effect of Levothyroxine (LT4) to BMD between short term and long term treatment." | 3.73 | The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women. ( Panichkul, S; Rajchadara, S; Sajjinanont, T; Sriassawaamorn, N, 2005) |
| "Patients with differentiated thyroid carcinoma (DTC) are commonly treated long-term with thyrotropin (TSH)- suppressive thyroxine replacement therapy resolving in a state of subclinical hyperthyroidism." | 3.73 | The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. ( Hamdy, NA; Heemstra, KA; Romijn, JA; Smit, JW, 2006) |
| "Patients with differentiated thyroid carcinoma (DTC) must receive suppressive levothyroxine (LT(4)) therapy for the rest of their lives." | 3.72 | Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment. ( Gallowitsch, HJ; Jauk, B; Jost, R; Kresnik, E; Leb, G; Lind, P; Mikosch, P; Obermayer-Pietsch, B, 2003) |
| "Patients with differentiated thyroid carcinoma (DTC) receive a life time l-thyroxine therapy in suppressive doses and may exhibit signs of cardiac hypertrophy." | 3.71 | [Effects of L-thyroxine suppressive therapy on cardiac mass in patients with differentiated thyroid cancer]. ( Czernik, E; Gubała, E; Jarzab, B; Kowalczyk, P; Matuszewska, G; Nowak, J; Roskosz, J; Sielańczyk, A, 2001) |
| "Life-time L-thyroxine therapy is obligatory in patients treated for differentiated thyroid carcinoma (DTC) in order to suppress serum TSH." | 3.71 | [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression]. ( Czernik, E; Gubała, E; Jarzab, B; Jurecka-Tuleja, B; Kowalczyk, P; Roskosz, J, 2001) |
| "To examine whether suppressive doses of thyroxine have any adverse effects on bone, we evaluated various bone metabolic markers (lectin-precipitated alkaline phosphatase, osteocalcin, carboxyl-terminal region of type I collagen propeptide, tartrate-resistant alkaline phosphatase, and urinary excretion of hydroxyproline and pyridinium crosslinks), incidence of vertebral deformity, total body and regional (lumbar spine and radius) bone mineral densities (BMDs), and rates of bone loss in 24 late postmenopausal (more than 5 years after menopause) women who were treated with levothyroxine (L-T4) after total thyroidectomy for differentiated carcinoma." | 3.69 | Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women. ( Ashizawa, K; Fujiyama, K; Ito, M; Kimura, H; Kiriyama, T; Nagataki, S; Nagayama, Y; Tsuruta, M; Villadolid, MC; Yokoyama, N, 1995) |
| " In papillary carcinoma thyroxine administration (P < 0." | 3.69 | Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. ( Staunton, MD, 1994) |
| "To determine bone mineral density in patients with differentiated thyroid carcinoma receiving thyroxine replacement therapy in suppressive doses, we studied 65 patients (47 women and 18 men; age 25-83 years, mean+/-SD 52." | 3.69 | Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma. ( Görres, G; Götze, M; Kaim, A; Müller-Brand, J; Otte, A, 1996) |
| "3 years) after thyroidectomy with or without subsequent radioablation for differentiated thyroid carcinoma, before and after the interruption of suppressive thyroxine (T4) replacement therapy for 5 weeks." | 3.67 | How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma? ( Lamberg, BA; Välimäki, M, 1985) |
| "03 microU/ml, in 183 patients operated upon for differentiated thyroid carcinoma and followed up while under treatment with L-thyroxine." | 3.67 | [Postoperative surveillance of differentiated thyroid epithelioma. Contribution of the ultrasensitive determination of TSH]. ( Comoy, E; De Vathaire, F; Fragu, P; Parmentier, C; Schlumberger, M; Wu-Ahouju, G, 1987) |
| "A comparative analysis of triiodothyronine (T3) and thyroxine (T4) distribution in organs and tissues of tumour-bearing and intact mice conducted wih 125J labelled T3 and T4 has shown considerable differences in the accumulation character of these hormones in mice with Lewis carcinoma and in intact animals in the liver, kidneys, lungs, adrenal glands, lymphatic nodes." | 3.67 | [Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma]. ( Dedenkov, AN; Norets, TA; Petrova, GA; Smoryzanova, OA; Vereshchagina, GV, 1985) |
| " Homogenates of human thyroid follicular adenoma and carcinomas were incubated with [125I]T4 and dithiothreitol (DTT) at 37 C for 60 min under N2 gas." | 3.66 | Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. ( Imura, H; Inada, M; Ishii, H; Mashio, Y; Naito, K; Nishikawa, M; Tanaka, K, 1981) |
| "The study was performed to evaluate the influence of thyroxine substitution therapy and the presence of thyroglobulin antibodies (TgAb) on the usefulness of serum thyroglobulin (Tg) measurements in the follow-up of patients treated for well differentiated thyroid carcinoma." | 3.66 | Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer. ( Feldt-Rasmussen, U; Hansen, HS; Holten, I, 1983) |
| "Forty patients with thyroid cancer submitted to thyroidectomy, who received 3." | 2.82 | Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants). ( Batista, KC; Calsolari, MR; Rosário, PW, 2016) |
| "UGT1A haplotypes associate with T4 dosage in DTC patients, but the effect accounts for only 2% of the total variability and recommendation of pre-emptive UGT1A genotyping is not warranted." | 2.79 | Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. ( Barros Filho, Mde C; Bulzico, DA; Kowalski, LP; Meirelles, RM; Neves, RR; Paula, DP; Pessoa, CN; Santoro, AB; Struchine, CJ; Suarez-Kurtz, G; Vargens, DD, 2014) |
| " However, careful titration of T4 dosage to maintain biochemical euthyroidism is a better way to avoid the adverse effect of T4 on bone." | 2.68 | Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. ( Kung, AW; Yeung, SS, 1996) |
| "We report a rare case of concurrent RT, acute suppurative thyroiditis, and micropapillary carcinoma in a 48-year-old patient." | 2.49 | Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma. ( Chu, YC; Hong, JT; Hong, SB; Kim, SH; Kim, YS; Lee, JH; Nam, M, 2013) |
| "Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all human tumors." | 2.48 | Approach to and treatment of differentiated thyroid carcinoma. ( Castagna, MG; Pacini, F, 2012) |
| "Its occurrence with differentiated thyroid cancer, particularly papillary thyroid carcinoma (PTC), even if rare, has been described." | 2.47 | Papillary thyroid carcinoma in Peutz-Jeghers syndrome. ( Bagnulo, R; Giagulli, VA; Guastamacchia, E; Lastella, P; Licchelli, B; Renzulli, G; Resta, F; Resta, N; Sabbà, C; Stella, A; Tafaro, E; Triggiani, V, 2011) |
| "Primary therapy of thyroid cancer is an adequate surgery: total thyreoidectomy and, if necessary, lymph node dissection or limited surgery in selected cases." | 2.47 | [Differentiated thyroid cancer -- 2009]. ( Konrády, A, 2011) |
| "Although thyroid nodules are common and cause concern about possible malignancy, relatively few are thyroid cancers, and relatively few thyroid cancers are lethal." | 2.39 | Thyroid nodules and the detection of thyroid cancer. ( Haber, RS, 1996) |
| "Thyroid cysts are rare in cats and poorly documented." | 1.46 | Thyroid Cysts in Cats: A Retrospective Study of 40 Cases. ( Broome, MR; Miller, ML; Norsworthy, GD; Peterson, ME; Randolph, JF; Rishniw, M, 2017) |
| "Hypothyroidism is an undesirable sequela of both surgery and radiotherapy, the two most commonly used modalities of treatment." | 1.43 | Postoperative hypofunctioning of the thyroid gland after total laryngectomy. ( Biswas, KD; Dutta, S; Ghatak, S; Haldar, D; Sen, I; Sinha, R, 2016) |
| " This model uses the patient's body surface area (BSA) along with the fractional whole-body retention (WBR) at 48 hours following oral administration of a diagnostic dosage of (131)I." | 1.42 | Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. ( Atkins, F; Burman, K; Moreau, S; Van Nostrand, D; Wartofsky, L, 2015) |
| "The cell lines may be useful for thyroid cancer research." | 1.40 | Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses. ( Hashimoto, H; Hirose, T; Ishikawa, M; Ito, T; Minami, S; Shibuya, K; Tachibana, T; Toyomura, J; Tsuboi, K; Yoshino, G, 2014) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| "Although functioning thyroid cancer metastases have been reported, they have almost never been reported for the clear cell variant of papillary thyroid carcinoma (PTC)." | 1.38 | Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma. ( Cho, BY; Chung, YJ; Lee, JI; Park, SJ; Ryu, HS, 2012) |
| "The best treatment option for recurrent papillary thyroid carcinoma (PTC) is reoperation when the recurrent lesion is locoregional." | 1.38 | Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation. ( Ahn, HY; Cho, BY; Choi, HS; Kim, KW; Kim, TH; Lee, EK; Lee, YJ; Lim, JA; Park, DJ; Park, YJ; Yi, KH, 2012) |
| "The likelihood of papillary thyroid carcinoma is reduced when TSH is lower, as in thyroid autonomy, and increased when TSH is higher, as in thyroid autoimmunity." | 1.38 | Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. ( Fiore, E; Vitti, P, 2012) |
| "This study evaluated the potential effects and dose-response relationship of LT(4) therapy on bone mineral density (BMD) as well as bone and muscle strength." | 1.38 | Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. ( Reiners, C; Schneider, M; Schneider, P; Schneider, R, 2012) |
| "Following thyroidectomy, a patient with papillary thyroid carcinoma was found to have widespread radioiodine-avid metastatic lesions and was treated with I-131." | 1.37 | Radioiodine dilution due to levothyroxine when using recombinant human thyroid-stimulating hormone: case report and discussion. ( Klein, HA, 2011) |
| "In Patient 1, histology showed a papillary thyroid carcinoma pT2." | 1.37 | Differentiated thyroid cancer in two patients with resistance to thyroid hormone. ( Capoluongo, E; Concolino, P; Corsello, SM; Locantore, P; Lovicu, RM; Paragliola, RM; Pontecorvi, A; Senes, P, 2011) |
| "Thyrotropin (TSH) changes in extreme primary hypothyroidism include increased secretion, slowed degradation, and diminished or absent TSH circadian rhythms." | 1.36 | TSH regulation dynamics in central and extreme primary hypothyroidism. ( DiStefano, JJ; Eisenberg, MC; Marsili, A; Pinchera, A; Santini, F, 2010) |
| "Patients with differentiated thyroid cancer (DTC) usually have a good prognosis but may experience a decline in quality of life (QOL)." | 1.35 | Illness perception in patients with differentiated epithelial cell thyroid cancer. ( Benbassat, C; Ginat, M; Grozinski-Glasberg, S; Hirsch, D; Levy, S; Mansiterski, Y; Reicher-Atir, R; Shimon, I; Shraga-Slutzky, I; Singer, J; Tsvetov, G; Weinstein, R, 2009) |
| "Four of five patients with lung metastases upon CT had a positive RxWBS." | 1.34 | Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131. ( Barroso, AL; Borges, MA; Costa, GB; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW, 2007) |
| "Differentiated thyroid cancers (DTC) often form metastases in neck lymph nodes, lungs and bones." | 1.33 | Hepatic metastasis of differentiated thyroid carcinoma. ( Kraft, O, 2005) |
| "Relative risk for thyroid cancer-related death and SMR are significantly increased in patients with stage T4 and M1 or advanced age." | 1.33 | Survival and death causes in differentiated thyroid carcinoma. ( Biermasz, NR; Corssmit, EP; Eustatia-Rutten, CF; Pereira, AM; Romijn, JA; Smit, JW, 2006) |
| "Hypothyroidism and hypoparathyroidism are common complications after treatment (surgery, radiotherapy and/or chemotherapy) for laryngo-pharyngeal carcinoma and other malignancies in the neck region." | 1.32 | [Clinical reasoning and decision making in practice. A man with unilateral attacks of muscular rigidity following neck surgery for a malignant tumor]. ( Bromberg, JE; Hart, W; Niermeijer, JM, 2003) |
| "Body weights were unaffected by PCN treatment, but were reduced 21% after 19 weeks of PCB treatment compared to control." | 1.32 | Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB). ( Habeebu, SM; Klaassen, CD; Muppidi, JR; Vansell, NR, 2004) |
| "Eleven patients with head and neck cancer (ten men, one woman; mean age, 65 years) (larynx, six; oropharynx, two; tongue, one; skin, one; thyroid, one) with regional lymph node enlargements either in contiguity or firmly adherent to the vascular structures of the neck have been treated by means of external microwaves (915, 434 MHz) applicators." | 1.28 | Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis. ( Airoldi, M; Brossa, PC; D'Alberto, M; Gabriele, P; Pedani, F; Ragona, R; Tseroni, V, 1990) |
| "Transition between thyroid and carcinoid occurred by proliferation of interfollicular cells which subtly formed trabecular structures." | 1.26 | Ovarian strumal carcinoid. An immunocytochemical and ultrastructural study of two cases. ( Ehrlich, CE; Roth, LM; Ulbright, TM, 1982) |
| "Plasma T3 levels were reduced in both breast cancer group, but were reduced only in colonic cancer patients with systemic metastases." | 1.26 | Plasma thyronine levels in carcinoma of the breast and colon. ( Davis, TE; Rose, DP, 1981) |
| "The reliability of pituitary suppression by administration of 1-thyroxin (t4) or a combination of thyroxin and triiodothyronin (t3) of variable dosage following radical surgery for thyroid cancer in 13 patients was investigated by means of TRH-test and measurement of serum hormone levels." | 1.25 | [Evaluation of reliable pituitary suppression therapy through varying thyroid hormone dosage following total thyroidectomy due to a differentiated thyroid carcinoma]. ( Hüfner, M; Papke, W; Röher, HD; Wahl, R, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (37.02) | 18.7374 |
| 1990's | 26 (14.36) | 18.2507 |
| 2000's | 30 (16.57) | 29.6817 |
| 2010's | 56 (30.94) | 24.3611 |
| 2020's | 2 (1.10) | 2.80 |
| Authors | Studies |
|---|---|
| Toda, S | 1 |
| Kadoya, M | 1 |
| Matsui, A | 1 |
| Murayama, D | 1 |
| Iwasaki, H | 1 |
| Huang, CH | 1 |
| Huang, TY | 1 |
| Chang, WJ | 1 |
| Pan, YS | 1 |
| Chu, HR | 1 |
| Li, ZL | 1 |
| Unson, S | 1 |
| Chin, YT | 1 |
| Lin, CY | 1 |
| Huang, HM | 1 |
| Hsiung, CN | 1 |
| Gionfra, F | 1 |
| De Vito, P | 1 |
| Pedersen, JZ | 1 |
| Incerpi, S | 1 |
| Chen, YR | 1 |
| Lee, SY | 1 |
| Lin, HY | 1 |
| Davis, PJ | 1 |
| Whang-Peng, J | 1 |
| Wang, K | 1 |
| Miller, ML | 1 |
| Peterson, ME | 1 |
| Randolph, JF | 1 |
| Broome, MR | 1 |
| Norsworthy, GD | 1 |
| Rishniw, M | 1 |
| Bellantone, R | 1 |
| Raffaelli, M | 1 |
| De Crea, C | 1 |
| Sessa, L | 1 |
| Traini, E | 1 |
| Princi, P | 1 |
| Lombardi, CP | 1 |
| Jin, S | 1 |
| Yang, YT | 1 |
| Bao, W | 1 |
| Bai, Y | 1 |
| Ai, JW | 1 |
| Liu, Y | 1 |
| Yong, H | 1 |
| Hong, JT | 1 |
| Lee, JH | 1 |
| Kim, SH | 1 |
| Hong, SB | 1 |
| Nam, M | 1 |
| Kim, YS | 1 |
| Chu, YC | 1 |
| Lin, Z | 2 |
| Chen, L | 2 |
| Fang, Y | 1 |
| Cai, A | 1 |
| Zhang, T | 1 |
| Wu, VW | 2 |
| Bernát, L | 1 |
| Hrušák, D | 1 |
| Ishikawa, M | 1 |
| Tachibana, T | 1 |
| Hashimoto, H | 2 |
| Toyomura, J | 1 |
| Ito, T | 1 |
| Tsuboi, K | 1 |
| Shibuya, K | 1 |
| Hirose, T | 1 |
| Minami, S | 2 |
| Yoshino, G | 1 |
| Vigário, Pdos S | 2 |
| Chachamovitz, DS | 2 |
| Teixeira, Pde F | 2 |
| Rocque, Mde L | 1 |
| Santos, ML | 1 |
| Vaisman, M | 2 |
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Santoro, AB | 1 |
| Vargens, DD | 1 |
| Barros Filho, Mde C | 1 |
| Bulzico, DA | 1 |
| Kowalski, LP | 1 |
| Meirelles, RM | 1 |
| Paula, DP | 1 |
| Neves, RR | 1 |
| Pessoa, CN | 1 |
| Struchine, CJ | 1 |
| Suarez-Kurtz, G | 1 |
| Lee, DY | 1 |
| Seok, J | 1 |
| Jeong, WJ | 1 |
| Ahn, SH | 1 |
| Rosario, PW | 6 |
| Calsolari, MR | 2 |
| Naghibi, SM | 1 |
| Ramezani, M | 1 |
| Ayati, N | 1 |
| Zakavi, SR | 1 |
| Xia, Q | 1 |
| Dong, S | 1 |
| Bian, PD | 1 |
| Wang, J | 1 |
| Li, CJ | 1 |
| Ito, M | 3 |
| Miyauchi, A | 3 |
| Kang, S | 1 |
| Hisakado, M | 1 |
| Yoshioka, W | 1 |
| Ide, A | 1 |
| Kudo, T | 2 |
| Nishihara, E | 2 |
| Kihara, M | 2 |
| Ito, Y | 3 |
| Kobayashi, K | 2 |
| Miya, A | 2 |
| Fukata, S | 1 |
| Nakamura, H | 1 |
| Amino, N | 2 |
| Del Duca, SC | 1 |
| Santaguida, MG | 1 |
| Brusca, N | 1 |
| Gatto, I | 1 |
| Cellini, M | 1 |
| Gargano, L | 1 |
| Verga Falzacappa, C | 1 |
| Frattaroli, FM | 1 |
| Virili, C | 1 |
| Centanni, M | 1 |
| Atkins, F | 1 |
| Van Nostrand, D | 1 |
| Moreau, S | 1 |
| Burman, K | 1 |
| Wartofsky, L | 1 |
| Handkiewicz-Junak, D | 1 |
| Gawlik, T | 1 |
| Rozkosz, J | 1 |
| Puch, Z | 1 |
| Michalik, B | 1 |
| Gubala, E | 1 |
| Krajewska, J | 1 |
| Kluczewska, A | 1 |
| Jarzab, B | 3 |
| Coura-Filho, GB | 1 |
| Willegaignon, J | 1 |
| Buchpiguel, CA | 1 |
| Sapienza, MT | 1 |
| Batista, KC | 1 |
| Dutta, S | 1 |
| Biswas, KD | 1 |
| Ghatak, S | 1 |
| Haldar, D | 1 |
| Sen, I | 1 |
| Sinha, R | 1 |
| Karls, S | 1 |
| Abikhzer, G | 1 |
| Tamilia, M | 1 |
| Probst, S | 1 |
| Ulusoy, E | 1 |
| Edeer-Karaca, N | 1 |
| Özen, S | 1 |
| Ertan, Y | 1 |
| Gökşen, D | 1 |
| Aksu, G | 1 |
| Darcan, Ş | 1 |
| Kütükçüler, N | 1 |
| Cecoli, F | 1 |
| Andraghetti, G | 1 |
| Ghiara, C | 1 |
| Briatore, L | 1 |
| Cavallero, D | 1 |
| Mussap, M | 1 |
| Minuto, F | 1 |
| Giusti, M | 1 |
| Panico, A | 1 |
| Lupoli, GA | 1 |
| Fonderico, F | 1 |
| Marciello, F | 1 |
| Martinelli, A | 1 |
| Assante, R | 1 |
| Lupoli, G | 1 |
| Hirsch, D | 1 |
| Ginat, M | 1 |
| Levy, S | 1 |
| Benbassat, C | 1 |
| Weinstein, R | 1 |
| Tsvetov, G | 1 |
| Singer, J | 1 |
| Shraga-Slutzky, I | 1 |
| Grozinski-Glasberg, S | 1 |
| Mansiterski, Y | 1 |
| Shimon, I | 1 |
| Reicher-Atir, R | 1 |
| Heemstra, KA | 3 |
| Burggraaf, J | 1 |
| van der Klaauw, AA | 1 |
| Romijn, JA | 5 |
| Smit, JW | 5 |
| Corssmit, EP | 4 |
| Giovanella, L | 1 |
| Maffioli, M | 1 |
| Ceriani, L | 1 |
| De Palma, D | 1 |
| Spriano, G | 1 |
| Nunes, Vdos S | 1 |
| Tagliarini, JV | 1 |
| Marques, ME | 1 |
| de Godoi, JA | 1 |
| Mazeto, GM | 1 |
| Abdulrahman, RM | 1 |
| Verloop, H | 1 |
| Hoftijzer, H | 1 |
| Verburg, E | 1 |
| Hovens, GC | 1 |
| Reiners, C | 3 |
| Gelderblom, H | 1 |
| Pereira, AM | 2 |
| Kapiteijn, E | 1 |
| Visser, TJ | 1 |
| Reverter, JL | 3 |
| Colomé, E | 2 |
| Puig Domingo, M | 1 |
| Julián, T | 1 |
| Halperin, I | 1 |
| Sanmartí, A | 3 |
| Gómez Sáez, JM | 1 |
| Holgado, S | 2 |
| Aguilera, E | 1 |
| Soldevila, B | 1 |
| Mateo, L | 1 |
| Lin, J | 1 |
| Feng, H | 1 |
| Emerson, CH | 1 |
| Eisenberg, MC | 1 |
| Santini, F | 1 |
| Marsili, A | 1 |
| Pinchera, A | 2 |
| DiStefano, JJ | 1 |
| Franco, AT | 1 |
| Malaguarnera, R | 1 |
| Refetoff, S | 2 |
| Liao, XH | 1 |
| Lundsmith, E | 1 |
| Kimura, S | 1 |
| Pritchard, C | 1 |
| Marais, R | 1 |
| Davies, TF | 1 |
| Weinstein, LS | 1 |
| Chen, M | 1 |
| Rosen, N | 1 |
| Ghossein, R | 1 |
| Knauf, JA | 1 |
| Fagin, JA | 1 |
| Konrády, A | 1 |
| Paragliola, RM | 1 |
| Lovicu, RM | 1 |
| Locantore, P | 1 |
| Senes, P | 1 |
| Concolino, P | 1 |
| Capoluongo, E | 1 |
| Pontecorvi, A | 1 |
| Corsello, SM | 1 |
| Santos, MA | 1 |
| Oliveira, FP | 1 |
| Binz, K | 1 |
| Haldemann, A | 1 |
| Meier, CA | 1 |
| Bohinc, BN | 1 |
| Parker, JC | 1 |
| Hope, WW | 1 |
| Kotwall, C | 1 |
| Turner, J | 1 |
| Cheng, W | 1 |
| Lloyd, RV | 1 |
| Triggiani, V | 1 |
| Guastamacchia, E | 1 |
| Renzulli, G | 1 |
| Giagulli, VA | 1 |
| Tafaro, E | 1 |
| Licchelli, B | 1 |
| Resta, F | 1 |
| Sabbà, C | 1 |
| Bagnulo, R | 1 |
| Lastella, P | 1 |
| Stella, A | 1 |
| Resta, N | 1 |
| Klein, HA | 1 |
| Malehmir, M | 1 |
| Haghpanah, V | 1 |
| Larijani, B | 1 |
| Ahmadian, S | 1 |
| Alimoghaddam, K | 1 |
| Heshmat, R | 1 |
| Ghavamzadeh, A | 1 |
| Adabi, K | 1 |
| Ghaffari, SH | 1 |
| Meringolo, D | 1 |
| Bianchi, D | 1 |
| Capula, C | 1 |
| Costante, G | 1 |
| Sugitani, I | 1 |
| Fujimoto, Y | 3 |
| Tanaka, K | 2 |
| Sonoo, H | 1 |
| Byrd, JK | 1 |
| Yawn, RJ | 1 |
| Wilhoit, CS | 1 |
| Sora, ND | 1 |
| Meyers, L | 1 |
| Fernandes, J | 1 |
| Day, T | 1 |
| Fiore, E | 1 |
| Vitti, P | 1 |
| Sisson, JC | 1 |
| Giordano, TJ | 1 |
| Avram, AM | 1 |
| Pacini, F | 2 |
| Castagna, MG | 2 |
| Hadfield, CA | 1 |
| Clayton, LA | 1 |
| Clancy, MM | 1 |
| Beck, SE | 1 |
| Mangus, LM | 1 |
| Montali, RJ | 1 |
| Tomoda, C | 1 |
| Morita, S | 1 |
| Takamura, Y | 1 |
| Kubota, S | 1 |
| Park, DJ | 1 |
| Lim, JA | 1 |
| Kim, TH | 1 |
| Choi, HS | 1 |
| Ahn, HY | 1 |
| Lee, EK | 1 |
| Lee, YJ | 1 |
| Kim, KW | 1 |
| Park, YJ | 1 |
| Yi, KH | 1 |
| Cho, BY | 2 |
| Lee, JI | 1 |
| Chung, YJ | 1 |
| Park, SJ | 1 |
| Ryu, HS | 1 |
| Yamazaki, CA | 1 |
| Padovani, RP | 1 |
| Biscolla, RP | 1 |
| Ikejiri, ES | 1 |
| Marchetti, RR | 1 |
| Castiglioni, ML | 1 |
| Matsumura, LK | 1 |
| Maciel, RM | 2 |
| Furlanetto, RP | 1 |
| Schneider, R | 1 |
| Schneider, M | 1 |
| Schneider, P | 1 |
| Psaltakos, V | 1 |
| Balatsouras, DG | 1 |
| Sengas, I | 1 |
| Ferekidis, E | 1 |
| Riga, M | 1 |
| Korres, SG | 1 |
| Mikosch, P | 1 |
| Obermayer-Pietsch, B | 1 |
| Jost, R | 1 |
| Jauk, B | 1 |
| Gallowitsch, HJ | 1 |
| Kresnik, E | 1 |
| Leb, G | 1 |
| Lind, P | 1 |
| BALME, HW | 1 |
| FLECK, F | 1 |
| SALVATORE, G | 1 |
| HALES, IB | 1 |
| REEVE, TS | 1 |
| STANLEY, PG | 1 |
| MYHILL, J | 1 |
| RICHARDS, M | 1 |
| Bromberg, JE | 1 |
| Niermeijer, JM | 1 |
| Hart, W | 1 |
| Vansell, NR | 1 |
| Muppidi, JR | 1 |
| Habeebu, SM | 1 |
| Klaassen, CD | 1 |
| Salvatori, M | 1 |
| Perotti, G | 1 |
| Rufini, V | 1 |
| Maussier, ML | 1 |
| Dottorini, M | 1 |
| Cardoso, LD | 2 |
| Fagundes, TA | 2 |
| Reis, JS | 1 |
| Maia, FF | 1 |
| Purisch, S | 4 |
| Kraft, O | 1 |
| Eustatia-Rutten, CF | 2 |
| Biermasz, NR | 1 |
| Alonso, N | 1 |
| Salinas, I | 1 |
| Granada, ML | 1 |
| Karner, I | 1 |
| Hrgović, Z | 1 |
| Sijanović, S | 1 |
| Buković, D | 1 |
| Klobucar, A | 1 |
| Usadel, KH | 1 |
| Fassbender, WJ | 1 |
| Padrão, EL | 3 |
| Rezende, LL | 3 |
| Barroso, AL | 3 |
| Jiang, JY | 1 |
| Tseng, FY | 1 |
| Vasconcelos, FP | 1 |
| Lauria, MW | 1 |
| Guimarães, VC | 1 |
| Hamdy, NA | 1 |
| Sajjinanont, T | 1 |
| Rajchadara, S | 1 |
| Sriassawaamorn, N | 1 |
| Panichkul, S | 1 |
| Nakagawa, Y | 1 |
| Mori, K | 1 |
| Hoshikawa, S | 1 |
| Ozaki, H | 1 |
| Ito, S | 1 |
| Yoshida, K | 1 |
| Dedecjus, M | 1 |
| Kołomecki, K | 1 |
| Brzeziński, J | 1 |
| Adamczewski, Z | 1 |
| Tazbir, J | 1 |
| Lewiński, A | 1 |
| Heijboer, AC | 1 |
| Frölich, M | 1 |
| Borges, MA | 1 |
| Costa, GB | 1 |
| McLaughlin, CM | 1 |
| Hunter, SJ | 1 |
| Bell, PM | 1 |
| McCance, DR | 1 |
| Sheridan, B | 1 |
| Atkinson, AB | 1 |
| Pelttari, H | 1 |
| Laitinen, K | 1 |
| Schalin-Jäntti, C | 1 |
| Välimäki, MJ | 1 |
| Harvard, CW | 1 |
| Tegler, L | 1 |
| Gillquist, J | 1 |
| Lindvall, R | 1 |
| Almqvist, S | 1 |
| Appelqvist, P | 1 |
| Kostianinen, S | 1 |
| Demidov, VP | 1 |
| Agranat, VZ | 1 |
| Ol'shanskiĭ, VO | 1 |
| Babakulyeva, D | 1 |
| Voronetskiĭ, IB | 1 |
| Mizukami, Y | 1 |
| Matsubara, F | 1 |
| Hashimoto, T | 1 |
| Haratake, J | 1 |
| Terahata, S | 1 |
| Noguchi, M | 1 |
| Hirose, K | 1 |
| Rose, DP | 1 |
| Davis, TE | 1 |
| Arnold, DL | 1 |
| Krewski, DR | 1 |
| Junkins, DB | 1 |
| McGuire, PF | 1 |
| Moodie, CA | 1 |
| Munro, IC | 1 |
| Feldt-Rasmussen, U | 1 |
| Holten, I | 1 |
| Hansen, HS | 1 |
| Ishii, H | 1 |
| Inada, M | 2 |
| Mashio, Y | 1 |
| Naito, K | 1 |
| Nishikawa, M | 1 |
| Imura, H | 1 |
| Thomas, CG | 1 |
| Rutledge, RG | 1 |
| Ulbright, TM | 1 |
| Roth, LM | 1 |
| Ehrlich, CE | 1 |
| Kawaoi, A | 1 |
| Okano, T | 1 |
| Nemoto, N | 1 |
| Shiina, Y | 1 |
| Shikata, T | 1 |
| Simpson, WJ | 1 |
| Prinz, RA | 1 |
| Oslapas, R | 1 |
| Hofmann, C | 1 |
| Shah, KH | 1 |
| Ernst, K | 1 |
| Refsguard, J | 1 |
| Lawrence, AM | 1 |
| Paloyan, E | 1 |
| Börner, W | 1 |
| Ohara, T | 1 |
| Richards, GE | 1 |
| Brewer, ED | 1 |
| Conley, SB | 1 |
| Saldana, LR | 1 |
| Clark, OH | 1 |
| Gemsenjäger, E | 1 |
| Girard, J | 1 |
| Sethi, VK | 1 |
| Waldstein, SS | 1 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 1 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Fujiyama, K | 1 |
| Kiriyama, T | 1 |
| Kimura, H | 1 |
| Ashizawa, K | 1 |
| Tsuruta, M | 1 |
| Nagayama, Y | 1 |
| Villadolid, MC | 1 |
| Yokoyama, N | 1 |
| Nagataki, S | 1 |
| Lecomte, P | 1 |
| Lecureuil, N | 1 |
| Osorio-Salazar, C | 1 |
| Lecureuil, M | 1 |
| Valat, C | 1 |
| Francia, G | 1 |
| Davì, MV | 1 |
| Petroziello, A | 1 |
| Sussi, PL | 1 |
| Smith, CD | 1 |
| Ain, KB | 1 |
| Staunton, MD | 2 |
| Marks, SL | 1 |
| Koblik, PD | 1 |
| Hornof, WJ | 1 |
| Feldman, EC | 1 |
| Stracke, H | 1 |
| Federlin, K | 1 |
| Görres, G | 1 |
| Kaim, A | 1 |
| Otte, A | 1 |
| Götze, M | 1 |
| Müller-Brand, J | 1 |
| Kung, AW | 1 |
| Yeung, SS | 1 |
| Lukinac, L | 1 |
| Franceschi, M | 1 |
| Nöthig-Hus, D | 1 |
| Lechpammer, S | 1 |
| Tomasić, J | 1 |
| Vranesić, B | 1 |
| Pape, E | 1 |
| Kusić, Z | 1 |
| Haber, RS | 1 |
| Pujol, P | 1 |
| Osman, A | 1 |
| Bringer, J | 1 |
| Jaffiol, C | 1 |
| Feldkamp, J | 1 |
| López Alvarez, MB | 1 |
| Hawkins, F | 1 |
| Rigopoulou, D | 1 |
| Martínez, G | 1 |
| Jodar, E | 1 |
| Estenoz, J | 1 |
| Ortuño, B | 1 |
| Arnaiz, F | 1 |
| Alagöl, F | 1 |
| Tanakol, R | 1 |
| Boztepe, H | 1 |
| Kapran, Y | 1 |
| Terzioglu, T | 1 |
| Dizdaroglu, F | 1 |
| Girelli, ME | 1 |
| Casara, D | 1 |
| Rubello, D | 1 |
| Mazzarotto, R | 1 |
| Saladini, G | 1 |
| Busnardo, B | 1 |
| Almeida-Filho, P | 1 |
| Ravizzini, GC | 1 |
| Almeida, C | 1 |
| Borges-Neto, S | 1 |
| Yasuhara, K | 1 |
| Koujitani, T | 1 |
| Takegawa, K | 1 |
| Nasu, M | 1 |
| Onodera, H | 1 |
| Takagi, H | 1 |
| Hirose, M | 1 |
| Mitsumori, K | 1 |
| Kowalczyk, P | 2 |
| Sielańczyk, A | 1 |
| Nowak, J | 1 |
| Matuszewska, G | 1 |
| Roskosz, J | 2 |
| Czernik, E | 2 |
| Gubała, E | 2 |
| Jurecka-Tuleja, B | 1 |
| Molinaro, E | 1 |
| Lippi, F | 1 |
| Agate, L | 1 |
| Ceccarelli, C | 1 |
| Taddei, D | 1 |
| Elisei, R | 1 |
| Capezzone, M | 1 |
| Harrison, J | 1 |
| Karanfilski, BT | 1 |
| Kaplan, EL | 1 |
| De Groot, LJ | 1 |
| Bekerman, C | 1 |
| Nagasaka, A | 1 |
| Hidaka, H | 1 |
| Arango, A | 1 |
| Lester, JL | 1 |
| Martinez, OV | 1 |
| Malinin, TI | 1 |
| Zeppa, R | 1 |
| Thom, AF | 1 |
| Marquezine, FJ | 1 |
| Kieffer, J | 1 |
| Ferraz, AR | 1 |
| Netto, A | 1 |
| Toledo, AC | 1 |
| Hasen, J | 1 |
| Goldiner, M | 1 |
| Volpert, EM | 1 |
| Prezyna, AP | 1 |
| Gaeta, JF | 1 |
| Koepf, GF | 1 |
| Wahl, R | 1 |
| Hüfner, M | 1 |
| Röher, HD | 2 |
| Papke, W | 1 |
| Greening, WP | 1 |
| Grabein, H | 1 |
| Wedell, J | 1 |
| van Calker, H | 1 |
| Gabuniia, RI | 1 |
| Romanova, LF | 1 |
| Pinkera, A | 1 |
| Matiakin, EG | 1 |
| Duditskaia, TK | 1 |
| Verschueren, CP | 1 |
| Selman, PJ | 1 |
| Mol, JA | 1 |
| Vos, JH | 1 |
| van Dijk, JE | 1 |
| Sjollema, BE | 1 |
| de Vijlder, JJ | 1 |
| Diamond, T | 1 |
| Nery, L | 1 |
| Hales, I | 1 |
| Hiasa, Y | 2 |
| Kitahori, Y | 2 |
| Kitamura, M | 1 |
| Nishioka, H | 1 |
| Yane, K | 1 |
| Fukumoto, M | 1 |
| Ohshima, M | 2 |
| Nakaoka, S | 1 |
| Nishii, S | 1 |
| Airoldi, M | 1 |
| Gabriele, P | 1 |
| Brossa, PC | 1 |
| Pedani, F | 1 |
| Tseroni, V | 1 |
| D'Alberto, M | 1 |
| Ragona, R | 1 |
| Harvey, RD | 1 |
| Matheson, NA | 1 |
| Grabowski, PS | 1 |
| Rodger, AB | 1 |
| Langer, HJ | 1 |
| Leicht, E | 1 |
| Koch, B | 1 |
| Weinheimer, B | 1 |
| Berberich, R | 1 |
| Strohfeldt, P | 1 |
| Weinges, KF | 1 |
| Wang, RL | 1 |
| Tan, YB | 1 |
| Lee, JK | 1 |
| Gordon, PR | 1 |
| Stall, GM | 1 |
| Gilchrest, BA | 1 |
| Kaplan, MM | 1 |
| Matsuki, H | 1 |
| Konishi, N | 1 |
| Thamavit, W | 1 |
| Poston, GJ | 1 |
| Thomas, AM | 1 |
| Macdonald, DW | 1 |
| Karvounaris, D | 1 |
| Henderson, BL | 1 |
| George, P | 1 |
| Lynn, JA | 1 |
| Lavender, JP | 1 |
| Schlumberger, M | 1 |
| De Vathaire, F | 1 |
| Wu-Ahouju, G | 1 |
| Comoy, E | 1 |
| Fragu, P | 1 |
| Parmentier, C | 1 |
| Baschieri, L | 1 |
| Antonelli, A | 1 |
| Del Guerra, P | 1 |
| Athanassiades, P | 1 |
| Piperingos, G | 1 |
| Pandos, P | 1 |
| Koutras, D | 1 |
| Moulopoulos, S | 1 |
| Lam, KS | 1 |
| Tse, VK | 1 |
| Wang, C | 1 |
| Yeung, RT | 1 |
| Ma, JT | 1 |
| Ho, JH | 1 |
| Vilde, F | 1 |
| Gehin-Fouque, F | 1 |
| Etling, N | 1 |
| Dedenkov, AN | 1 |
| Petrova, GA | 1 |
| Smoryzanova, OA | 1 |
| Norets, TA | 1 |
| Vereshchagina, GV | 1 |
| Välimäki, M | 1 |
| Lamberg, BA | 1 |
| Spitsa, AI | 2 |
| Arkhipenko, VI | 2 |
| Ouchi, Y | 1 |
| Ouchi, S | 1 |
| Hachiya, T | 1 |
| Yoshimura, M | 1 |
| Abe, S | 1 |
| Pochin, EE | 1 |
| Gutmann, L | 1 |
| Crosby, TW | 1 |
| Takamori, M | 1 |
| Martin, JD | 1 |
| Bellabarba, D | 1 |
| Varsano-Aharon, N | 1 |
| Sterling, K | 1 |
| Melander, A | 1 |
| Thomas-Morvan, C | 1 |
| Nataf, B | 1 |
| Tubiana, M | 1 |
| Richardson, JE | 1 |
| Wade, JS | 1 |
| Samaan, NA | 1 |
| Beceiro, JR | 1 |
| Hill, CS | 1 |
| Haynie, TP | 1 |
| Glenn, HJ | 1 |
| Shah, DH | 1 |
| Thakare, UR | 1 |
| Shownkeen, RC | 1 |
| Pahuja, DN | 1 |
| Mandlik, MY | 1 |
| Hill, LD | 1 |
| Beebe, HG | 1 |
| Hipp, R | 1 |
| Jones, HW | 1 |
| Desai, KB | 1 |
| Mehta, MN | 1 |
| Patel, MC | 1 |
| Sharma, SM | 1 |
| Ramanna, L | 1 |
| Ganatra, RD | 1 |
| McKenzie, JM | 1 |
| Murphy, SS | 1 |
| Gubler, R | 1 |
| Meyer, BJ | 1 |
| Bieler, EU | 1 |
| Jansen, CR | 1 |
| Mayberry, WE | 1 |
| Gharib, H | 1 |
| Bilstad, JM | 1 |
| Sizemore, GW | 1 |
| Blackburn, G | 1 |
| Bokelmann, D | 1 |
| Dörr, D | 1 |
| Linder, F | 1 |
| Oellers, B | 1 |
| Rudolph, H | 1 |
| Trumm, FA | 1 |
| Cherry, CP | 2 |
| Glucksmann, A | 1 |
| Taylor, S | 1 |
| Davis, PW | 1 |
| Glucksman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyroid Stimulating Hormone in Glomerular Filtration Rate During Radioiodine Therapy[NCT01945125] | 28 participants (Actual) | Interventional | 2011-10-31 | Completed | |||
| Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma[NCT00887107] | Phase 2 | 32 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| Cognitive Functions and Mood During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma[NCT02665325] | 100 participants (Anticipated) | Observational | 2016-01-31 | Recruiting | |||
| Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples[NCT06133374] | 130 participants (Anticipated) | Observational | 2023-12-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for thyroxine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma.
Topics: Anti-Bacterial Agents; Biopsy; Carcinoma; Carcinoma, Papillary; Female; Hashimoto Disease; Hormone R | 2013 |
[Differentiated thyroid cancer -- 2009].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Medullary | 2011 |
[Differentiated thyroid carcinoma--essential for the practitioner].
Topics: Carcinoma; Combined Modality Therapy; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Thyroid Ne | 2011 |
Papillary thyroid carcinoma in Peutz-Jeghers syndrome.
Topics: AMP-Activated Protein Kinase Kinases; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Female; | 2011 |
Well differentiated thyroid carcinoma: current treatment.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; N | 2012 |
Approach to and treatment of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Combined Modality | 2012 |
[Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma].
Topics: Carcinoma; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Neoplasm Recurrence, Loc | 2005 |
[Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer?].
Topics: Algorithms; Biological Assay; Carcinoma; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Pra | 2007 |
Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
Topics: Carcinoma; Cell Differentiation; Clinical Audit; Humans; Iodine Radioisotopes; Middle Aged; Radionuc | 2008 |
The thyroid and ageing.
Topics: Age Factors; Aged; Aging; Alpha-Globulins; Animals; Carcinoma; Humans; Hyperthyroidism; Hypothyroidi | 1981 |
Multiple thoracotomy combined with chemotherapy in metastatic adrenal cortical carcinoma: a case report and review of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Carcinoma; Cortisone; Cushing Syndrom | 1983 |
Thyroid nodules and the detection of thyroid cancer.
Topics: Adult; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Patient Selection; Risk Factors; Thyroid | 1996 |
[Endocrine therapy and after-care in thyroid gland carcinoma].
Topics: Aftercare; Carcinoma; Combined Modality Therapy; Humans; Neoplasm Staging; Thyroid Neoplasms; Thyrot | 1998 |
Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
Topics: Biopsy; Carcinoma; Fatal Outcome; Female; Goiter, Nodular; Humans; Middle Aged; Propranolol; Thyroid | 1999 |
Radioiodine therapy of thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Biopsy; Bone Marrow Diseases; Carcinoma; Half-Life; Human | 1971 |
Treatment of the thyroid nodule.
Topics: Adenocarcinoma; Autopsy; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Humans; Hyperthyr | 1971 |
11 trials available for thyroxine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
Topics: Adult; Autoantibodies; Carcinoma; Cross-Sectional Studies; Education; Exercise; Female; Humans; Hype | 2014 |
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Cohort Studies; Dose-Response Re | 2014 |
Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyrotropin on Glomerular Filtration Rate During Radioiodine Therapy for Well-Differentiated Thyroid Cancer.
Topics: Adult; Carcinoma; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Glomerular Filtrat | 2015 |
Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants).
Topics: Adult; Analysis of Variance; Antioxidants; Ascorbic Acid; Carcinoma; Dietary Supplements; Dinoprost; | 2016 |
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
Topics: Aged; Aged, 80 and over; Benzenesulfonates; Carcinoma; Female; Humans; Hypothyroidism; Male; Middle | 2010 |
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.
Topics: Adult; Aged; Bone Density; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Middl | 2011 |
Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Iodine Radi | 2012 |
Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Topics: Antineoplastic Agents; Bone Density; Bone Diseases, Metabolic; Carcinoma; Female; Femur Neck; Humans | 2005 |
Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma.
Topics: Blood Platelets; Carcinoma; Case-Control Studies; Cell Separation; Female; Humans; Hypothyroidism; M | 2007 |
Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
Topics: Adult; Carcinoma; Female; Glucose Intolerance; Humans; Hyperthyroidism; Insulin; Lipids; Male; Middl | 2006 |
Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
Topics: Biomarkers; Bone and Bones; Bone Density; Calcitonin; Calcium; Carcinoma; Female; Humans; Middle Age | 1996 |
154 other studies available for thyroxine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.
Topics: Carcinoma; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Methimazole; Middle Aged; Thyroglobu | 2022 |
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, | 2020 |
Thyroid Cysts in Cats: A Retrospective Study of 40 Cases.
Topics: Animals; Carcinoma; Cat Diseases; Cats; Cystadenoma; Cysts; Female; Iodine Radioisotopes; Magnetic R | 2017 |
Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine | 2018 |
Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
Topics: Adult; Anomia; Carcinoma; Cognitive Dysfunction; Female; Hormone Replacement Therapy; Humans; Male; | 2019 |
Longitudinal study on the correlations of thyroid antibody and thyroid hormone levels after radiotherapy in patients with nasopharyngeal carcinoma with radiation-induced hypothyroidism.
Topics: Adult; Aged; Autoantibodies; Biomarkers; Carcinoma; Female; Follow-Up Studies; Humans; Hypothyroidis | 2014 |
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
Topics: Adolescent; Adult; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Cell Transf | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
Prediction of thyroid hormone supplementation after thyroid lobectomy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Hormone Replacement Therapy | 2015 |
Should a family history of papillary thyroid carcinoma indicate more aggressive therapy in patients with this tumor?
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Family Health; Female; | 2014 |
Carum induced hypothyroidism: an interesting observation and an experiment.
Topics: Carcinoma; Carcinoma, Papillary; Carum; Female; Humans; Hypothyroidism; Thyroid Cancer, Papillary; T | 2015 |
Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; China; Female; Hormone Replacement Therapy | 2016 |
Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Hormone Replacement Therapy; H | 2015 |
Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
Topics: Carcinoma; Dose-Response Relationship, Drug; Female; Hormone Replacement Therapy; Humans; Hypothyroi | 2015 |
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I.
Topics: Body Surface Area; Carcinoma; Female; Humans; Iodine Radioisotopes; Linear Models; Male; Radiometry; | 2015 |
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Carcinoma; Carcinoma, Papillary; Child; Humans; Iodine Radio | 2015 |
Postoperative hypofunctioning of the thyroid gland after total laryngectomy.
Topics: Adult; Carcinoma; Follow-Up Studies; Humans; Hypothyroidism; India; Laryngeal Neoplasms; Laryngectom | 2016 |
Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer: Comparing Thyroxine Withdrawal With Recombinant Thyrotropin Preparation Techniques.
Topics: Adult; Aged; Carcinoma; Drug Administration Schedule; Female; Humans; Iodine Radioisotopes; Male; Mi | 2017 |
An unusual manifestation: Papillary thyroid carcinoma in a patient with ataxia-telengiectasia.
Topics: Adolescent; Ataxia Telangiectasia; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Ra | 2016 |
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing.
Topics: Adult; Aged; Carcinoma; Female; Humans; Leptin; Middle Aged; Recombinant Proteins; Thyroid Neoplasms | 2008 |
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; | 2009 |
Illness perception in patients with differentiated epithelial cell thyroid cancer.
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinom | 2009 |
Short-term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized differentiated thyroid carcinoma patients.
Topics: Adult; Autonomic Nervous System; Carcinoma; Case-Control Studies; Catecholamines; Female; Heart Rate | 2010 |
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Humans; Immunoradiometric Assay; Male; Middle Aged; Neoplasm Recurre | 2009 |
A patient with Graves' disease and three types of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Fatal Outcome; Female; Graves Disease; Humans; Neoplasm | 2010 |
[Clinical endocrinologists' perception of the deleterious effects of TSH suppressive therapy in patients with differentiated thyroid carcinoma].
Topics: Adult; Attitude of Health Personnel; Carcinoma; Cognition Disorders; Cross-Sectional Studies; Data C | 2010 |
[Is our approach to thyroid nodules and differentiated thyroid carcinoma in agreement with the American guideline and European consensus?].
Topics: Carcinoma; Consensus Development Conferences as Topic; Cross-Sectional Studies; Data Collection; Dru | 2010 |
Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.
Topics: Bone Density; Carcinoma; Fractures, Bone; Humans; Male; Thyroid Neoplasms; Thyroxine; Vitamin D | 2010 |
A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nasopharyngeal Carc | 2011 |
Anthropomorphic thyroidopathies?
Topics: Adult; Body Mass Index; Carcinoma; Child, Preschool; Fasting; Humans; Hypothyroidism; Insulin; Lepti | 2010 |
TSH regulation dynamics in central and extreme primary hypothyroidism.
Topics: Carcinoma; Circadian Rhythm; Computer Simulation; Feedback; Humans; Hypothyroidism; Iodine Radioisot | 2010 |
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.
Topics: Animals; Carcinoma; Carcinoma, Papillary; Female; Gene Expression; Humans; Immunohistochemistry; Iod | 2011 |
Differentiated thyroid cancer in two patients with resistance to thyroid hormone.
Topics: Carcinoma; Carcinoma, Papillary; Humans; Male; Middle Aged; Thyroid Cancer, Papillary; Thyroid Hormo | 2011 |
Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism.
Topics: Adaptation, Physiological; Blood Pressure; Carcinoma; Epidemiologic Methods; Exercise Test; Female; | 2011 |
Micropapillary thyroid carcinoma and concomitant ectopic thyroid tissue in the adrenal gland: metastasis or metaplasia?
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; C | 2011 |
Radioiodine dilution due to levothyroxine when using recombinant human thyroid-stimulating hormone: case report and discussion.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Humans; Indicator Dilution Techniques; Iodine Radioisotopes; | 2011 |
Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation.
Topics: Antigens, Differentiation; Antineoplastic Agents; Carcinoma; Cell Dedifferentiation; Cell Differenti | 2012 |
Papillary thyroid microcarcinoma in struma ovarii.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Strum | 2012 |
Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.
Topics: Carcinoma; Carcinoma, Papillary; Chemotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Japan | 2012 |
Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.
Topics: Animals; Carcinoma; Carcinoma, Papillary; Humans; Molecular Targeted Therapy; Neoplasm Staging; Prac | 2012 |
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Anti-Inflammatory Agents; Biopsy, Fine | 2012 |
Proliferative thyroid lesions in three diplodactylid geckos: Nephrurus amyae, Nephrurus levis, and Oedura marmorata.
Topics: Animals; Animals, Zoo; Carcinoma; Fatal Outcome; Hyperplasia; Hypothyroidism; Lizards; Male; Thyroid | 2012 |
Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Female; Humans; Male; Middl | 2012 |
TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Preoperative Care; | 2012 |
Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Neck; Neoplasm Recu | 2012 |
Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Radionuclide | 2012 |
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
Topics: Adult; Bone Density; Carcinoma; Cohort Studies; Female; Goiter; Hormone Replacement Therapy; Humans; | 2012 |
Cochlear dysfunction in patients with acute hypothyroidism.
Topics: Acoustic Impedance Tests; Adult; Audiometry, Pure-Tone; Auditory Threshold; Carcinoma; Case-Control | 2013 |
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Carcinoma; Dose-Response Relationship, D | 2003 |
Metastatic carcinoma of the thyroid successfully treated with thyroxine.
Topics: Carcinoma; Humans; Lung Neoplasms; Neoplasms; Thyroid Gland; Thyroid Neoplasms; Thyroxine | 1954 |
[Treatment of roentgen carcinoma by hypervitaminization with axerophtholen].
Topics: Carcinoma; Humans; Skin Neoplasms; Thyroxine; Vitamin A | 1954 |
[INTRACELLULAR PENETRATION OF THYROID HORMONES].
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Chromatography; Electrophoresis; Erythrocytes; Escheri | 1964 |
FUNCTIONING FOLLICULAR METASTATIC CARCINOMA OF THE THYROID.
Topics: Carcinoma; Humans; Iodine Isotopes; Neoplasm Metastasis; Neoplasms; Pathology; Pharmacology; Thoraci | 1964 |
[Clinical reasoning and decision making in practice. A man with unilateral attacks of muscular rigidity following neck surgery for a malignant tumor].
Topics: Calcium; Carcinoma; Chemotherapy, Adjuvant; Diagnosis, Differential; Humans; Hypoparathyroidism; Mag | 2003 |
Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB).
Topics: Adenoma; Animals; Antithyroid Agents; Body Weight; Carcinoma; Chlorodiphenyl (54% Chlorine); Eating; | 2004 |
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Humans; Iodine Radiois | 2004 |
[Usefulness of radioiodine scanning in patients with moderate/high risk differentiated thyroid carcinoma in whom thyroglobulin after thyroxin withdrawal is undetectable after initial treatment].
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionu | 2004 |
Hepatic metastasis of differentiated thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Cell Differentiation; Humans; Iodine Radioisotopes; Liver; Liver | 2005 |
Survival and death causes in differentiated thyroid carcinoma.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Carcinoma; Cause of Death; Endpoint Determination; F | 2006 |
Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone and Bones; Bone Density; Calcium; Carcinoma; Cohort | 2005 |
Prognostic factors of anaplastic thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Female; Goiter; Humans; Leukoc | 2006 |
Managing thyroid cancer without thyroxine withdrawal.
Topics: Adult; Carcinoma; Case-Control Studies; Cholesterol, LDL; Creatine Kinase; Female; Humans; Immunorad | 2006 |
The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Bone and Bones; Carcinoma; Cell Differentiation; Databases, Bibliographic; Female; Huma | 2006 |
The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
Topics: Adult; Bone Density; Carcinoma; Case-Control Studies; Drug Administration Schedule; Female; Humans; | 2005 |
Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer.
Topics: Adult; Carcinoma; Female; Goiter, Nodular; Graves Disease; Hormone Replacement Therapy; Humans; Hype | 2007 |
Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Female; Humans; Iodine Radioisotopes; Lung Ne | 2007 |
Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment.
Topics: Adolescent; Adult; Aged; Carcinoma; Cell Differentiation; Child; Female; Follow-Up Studies; Hormone | 2008 |
Secretion rates of thyroxine, triiodothyronine, and reverse triiodothyronine in man during surgery.
Topics: Adenoma; Adult; Aged; Carcinoma; Electromagnetic Phenomena; Female; Goiter; Goiter, Nodular; Humans; | 1982 |
[Hormone-secreting tumors in the thyroid and parathyroid glands. Morphological studies].
Topics: Adenocarcinoma; Calcitonin; Carcinoma; Humans; Parathyroid Neoplasms; Thyroid Neoplasms; Thyroxine | 1983 |
[Thyroid activity in patients with thyroid neoplasms].
Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Sex Fac | 1983 |
Primary mucoepidermoid carcinoma in the thyroid gland. A case report including an ultrastructural and biochemical study.
Topics: Adenocarcinoma; Adult; Carcinoma; Diagnosis, Differential; Female; Humans; Lymph Nodes; Microscopy, | 1984 |
Plasma thyronine levels in carcinoma of the breast and colon.
Topics: Adult; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged; | 1981 |
Reversibility of ethylenethiourea-induced thyroid lesions.
Topics: Adenoma; Animals; Body Weight; Carcinoma; Diet; Dose-Response Relationship, Drug; Ethylenethiourea; | 1983 |
Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer.
Topics: Adolescent; Adult; Aged; Autoantibodies; Carcinoma; Female; Follow-Up Studies; Humans; Male; Methods | 1983 |
Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
Topics: Adenoma; Carcinoma; Dithiothreitol; Graves Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Th | 1981 |
Surgical intervention in chronic (Hashimoto's) thyroiditis.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma; Diagnosis, Differential; Female; Goiter, Nodular; Humans; Io | 1981 |
Ovarian strumal carcinoid. An immunocytochemical and ultrastructural study of two cases.
Topics: Aged; Calcitonin; Carcinoid Tumor; Carcinoma; Female; Humans; Immunoenzyme Techniques; Middle Aged; | 1982 |
Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.
Topics: Adenocarcinoma; Adenoma; Carcinoma; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cystadenoma; Hum | 1982 |
Thyroid malignancy in the elderly.
Topics: Adenocarcinoma; Aged; Carcinoma; Carcinoma, Papillary; Carcinoma, Squamous Cell; Fibrosarcoma; Human | 1982 |
Long-term effect of radiation on thyroid function and tumor formation.
Topics: Adenocarcinoma; Adenoma; Animals; Brain Neoplasms; Calcitonin; Carcinoma; Female; Male; Medulla Oblo | 1982 |
[Specific follow-up program for thyroid cancer].
Topics: Carcinoma; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Radionuclide | 1982 |
[Endocrine aspects of thyroid cancer].
Topics: Adenocarcinoma, Papillary; Adult; Aged; Calcitonin; Carcinoma; Female; Humans; Male; Middle Aged; Th | 1982 |
Combined hypothyroidism and hypoparathyroidism in an infant after maternal 131I administration.
Topics: Carcinoma; Female; Humans; Hypocalcemia; Hypoparathyroidism; Hypothyroidism; Infant; Infant, Newborn | 1981 |
TSH suppression in the management of thyroid nodules and thyroid cancer.
Topics: Adenoma; Carcinoma; Goiter; Humans; Thyroid Diseases; Thyroid Hormones; Thyroid Neoplasms; Thyroidit | 1981 |
[Preclinical hyperthyroidism in thyroid invasion by tumors of other organs].
Topics: Adenocarcinoma; Carcinoma; Female; Humans; Hyperthyroidism; Kidney Neoplasms; Lymphoma; Male; Middle | 1981 |
Non-surgical treatment of thyroid carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Carcinoma; Humans; Iodine Radioisotopes; Thyroid Neoplasm | 1981 |
Suppressive therapy in the management of metastatic thyroid carcinoma.
Topics: Adenocarcinoma; Anaplasia; Carcinoma; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Thyroid Neo | 1980 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.
Topics: Aged; Aging; Bone Density; Carcinoma; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fem | 1995 |
Effects of suppressive doses of levothyroxine treatment on sex-hormone-binding globulin and bone metabolism.
Topics: Adult; Body Weight; Bone and Bones; Bone Density; Carcinoma; Female; Goiter; Humans; Liver; Middle A | 1995 |
[Hormonal therapy in differentiated carcinoma of the thyroid gland].
Topics: Adenocarcinoma, Follicular; Adenylyl Cyclases; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; H | 1994 |
Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy.
Topics: Acute Disease; Adult; Brain; Carcinoma; Energy Metabolism; Humans; Hypothyroidism; Magnetic Resonanc | 1995 |
Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Femal | 1994 |
99mTc-pertechnetate imaging of thyroid tumors in dogs: 29 cases (1980-1992).
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma; Carcinoma, Medullary; Dog Diseases; Dogs; Female; Lung | 1994 |
BGP serum levels in patients with thyroid carcinoma before and 4-14 weeks after radioiodine therapy.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Carcinoma; Female; Humans; Iodine Radioisotopes; Male | 1993 |
Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Carcinoma; Case-Control Studies; Female; Hip; Humans; | 1996 |
Endogenously labeled thyroid hormones (131I-T3/T4) in sera of patients with differentiated thyroid carcinoma.
Topics: Adult; Carcinoma; Chromatography; Female; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; | 1996 |
Prevention of thyroid neoplasm recurrence with Triac and levothyroxine.
Topics: Carcinoma; Drug Therapy, Combination; Humans; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyroxi | 1997 |
[The risk factors and bone mineral density in women on long-term levothyroxine treatment].
Topics: Adult; Aged; Bone Density; Carcinoma; Combined Modality Therapy; Female; Humans; Linear Models; Midd | 1999 |
Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients.
Topics: Aged; Carcinoma; Combined Modality Therapy; Humans; Iodine Radioisotopes; Longitudinal Studies; Lymp | 1999 |
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Follo | 2000 |
Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action.
Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Dose-Response Relationship, Drug; Female; Hyp | 2001 |
[Effects of L-thyroxine suppressive therapy on cardiac mass in patients with differentiated thyroid cancer].
Topics: Adult; Aged; Carcinoma; Cardiomegaly; Female; Humans; Male; Middle Aged; Thyroid Neoplasms; Thyroxin | 2001 |
[L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
Topics: Adult; Carcinoma; Female; Humans; Male; Thyroid Neoplasms; Thyrotropin; Thyroxine | 2001 |
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Postoperative Period; Prognos | 2001 |
Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood.
Topics: Acne Vulgaris; Adenoids; Adolescent; Adult; Autoantibodies; Carcinoma; Chicago; Child; Child, Presch | 1975 |
Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenoma; Calcium; Carcinoma; Cyclic AMP; Cyclic GMP; Enzyme Act | 1976 |
Bacteriologic and systemic effects of intraoperative segmental bowel preparation with povidone iodine.
Topics: Adult; Aged; Bacteria; Carcinoma; Colon; Colonic Diseases; Colonic Neoplasms; Humans; Iodine; Middle | 1979 |
[Treatment of thyroid carcinoma].
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Doxorubicin; Female; Follow-Up Studies; Humans; Iodine Ra | 1978 |
Triiodothyronine-producing metastatic follicular thyroid carcinoma.
Topics: Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Thyroid Neoplasms; Thyro | 1977 |
Iodoamino acid content and distribution in normal and abnormal human thyroids.
Topics: Adenoma; Carcinoma; Humans; Monoiodotyrosine; Thyroid Gland; Thyroid Neoplasms; Thyroiditis, Autoimm | 1975 |
[Evaluation of reliable pituitary suppression therapy through varying thyroid hormone dosage following total thyroidectomy due to a differentiated thyroid carcinoma].
Topics: Carcinoma; Humans; Pituitary Gland; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Thyrot | 1975 |
Treatment of thyroid cancer in 293 patients.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lympha | 1976 |
[Atypical thyroid gland adenoma. Experiences during 12 years struma surgery].
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Diagnosis | 1991 |
[Radioimmunologic analysis in the differential diagnosis of cancer of the thyroid gland].
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Biomarkers, Tumor; Carcinoma; Diagnosis, Differential; Female; | 1991 |
Circulating thyroglobulin measurements by homologous radioimmunoassay in dogs with thyroid carcinoma.
Topics: Adenoma; Animals; Carcinoma; Dogs; Female; Flow Cytometry; Male; Ploidies; Radioimmunoassay; Thyrogl | 1991 |
A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
Topics: Adult; Bone Density; Carcinoma; Female; Humans; Menopause; Middle Aged; Thyroid Neoplasms; Thyroxine | 1991 |
Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine.
Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Dose-Response Relationship, Drug; Female; Mal | 1991 |
Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Human | 1990 |
Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Female; Humans; Male; Middle | 1990 |
[Familial nonneoplastic inappropriate thyrotropin secretion].
Topics: Carcinoma; Diagnosis, Differential; Drug Therapy, Combination; Female; Goiter; Humans; Middle Aged; | 1990 |
[Immunohistochemical study and lectin distribution of thyroid carcinoma originated from follicular epithelium].
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Papillary; Humans; Immunohistochemistry; Lectins; Thyroglobuli | 1990 |
Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line.
Topics: Carcinoma; Cell Differentiation; Colonic Neoplasms; Humans; Intestinal Absorption; Iodine; Kinetics; | 1989 |
Promoting effect of 2,4-diaminoanisole sulfate on rat thyroid carcinogenesis.
Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Cocarcinogenesis; Hair Dyes; Hair Preparation | 1989 |
Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Topics: 3-Iodobenzylguanidine; Adult; Calcitonin; Carcinoma; Epinephrine; Female; Humans; Iodine Radioisotop | 1986 |
[Postoperative surveillance of differentiated thyroid epithelioma. Contribution of the ultrasensitive determination of TSH].
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Follow-Up Studies; Humans; Hyperthyroidism; Male; Middle | 1987 |
[Therapeutic strategy in thyroid carcinoma].
Topics: Adenoma; Adolescent; Adult; Carcinoma; Carcinoma, Papillary; Child; Female; Follow-Up Studies; Human | 1987 |
Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma; Cisplatin; Combi | 1988 |
Early effects of cranial irradiation on hypothalamic-pituitary function.
Topics: Adult; Carcinoma; Estradiol; Female; Follow-Up Studies; Humans; Hydrocortisone; Hyperprolactinemia; | 1987 |
[Biochemical and microscopic (optic and electron) comparative study of normal and tumoral thyroid tissues in man].
Topics: Adenoma; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Humans; Iodine; Midd | 1985 |
[Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma].
Topics: Animals; Carcinoma; Female; Kinetics; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Transplan | 1985 |
How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?
Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iodine Radiois | 1985 |
[The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
Topics: Antibiotics, Antineoplastic; Carcinoma; Dactinomycin; Female; Flavonoids; In Vitro Techniques; Insul | 1971 |
[Triosorb, tetrasorb and T3 values as indicators of thyroid function].
Topics: Carcinoma; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Male; Pregnancy; Thyroid Functio | 1971 |
The Eaton-Lambert syndrome and autoimmune disorders.
Topics: Adult; Anemia, Pernicious; Autoimmune Diseases; Bronchial Neoplasms; Carcinoma; Electrodiagnosis; Hu | 1972 |
Thyroxine transport and turnover in major nonthyroidal illness.
Topics: Adenocarcinoma; Adult; Aged; Biological Transport; Blood Proteins; Carcinoma; Carcinoma, Bronchogeni | 1968 |
Bioassay of calcitonin by determinations of blood calcium-45 levels in rats and mice.
Topics: Adrenocorticotropic Hormone; Animals; Biological Assay; Calcitonin; Calcium; Calcium Isotopes; Calci | 1973 |
Thyroid proteins and hormone synthesis in human thyroid cancer.
Topics: Adenocarcinoma; Carbon Radioisotopes; Carcinoma; Carcinoma, Papillary; Chromatography, Paper; Diiodo | 1974 |
[Interaction of the cells of some lines obtained from tumorous and embryonic tissues].
Topics: Animals; Carcinoma; Cell Division; Cell Line; Cells, Cultured; Colchicine; Culture Media; Cytologica | 1974 |
On certain aspects of thyrotoxicosis and thyroid carcinoma.
Topics: Adolescent; Adult; Age Factors; Aged; Carcinoma; Child; Child, Preschool; Female; History, 18th Cent | 1973 |
Clinical research in thyroid surgery.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Calcium; Carcinoma; Carcinoma, Papillary; Edetic Acid; Goi | 1972 |
Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
Topics: Adenocarcinoma; Aged; Carcinoma; Female; Half-Life; Humans; Injections, Intravenous; Iodine; Iodine | 1972 |
Iodinated thyrolipids: their possible role in homonogenesis.
Topics: Animals; Carcinoma; Cystadenoma; Goiter, Nodular; Graves Disease; Humans; In Vitro Techniques; Iodin | 1973 |
Proceedings: Thyroid suppression.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Humans; Iod | 1974 |
Familial goitre with absence of thyroglobulin and synthesis of thyroid hormones from thyroidal albumin.
Topics: Adolescent; Albumins; Carcinoma; Centrifugation, Density Gradient; Child; Chromatography; Chromatogr | 1974 |
[Therapy of malignant tumors of the thyroid gland].
Topics: Adenocarcinoma; Carcinoma; Humans; Iodine Isotopes; Radiotherapy, High-Energy; Sarcoma; Thyroid Neop | 1966 |
Diagnosis of thyroid disorders using radio-active iodine isotopes. Experiences and results 1962-1971.
Topics: Adenoma; Carcinoma; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; M | 1972 |
Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function.
Topics: Adolescent; Adult; Age Factors; Aged; Basal Metabolism; Blood Proteins; Carcinoma; Child; Child, Pre | 1971 |
Carcinoma of the thyroid.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Isotopes; Male | 1969 |
[Pathology and therapy of struma maligna].
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Female; Humans; Iodine Isotopes; Male; Middle Aged; Neopl | 1970 |
The influence of thyroactive substances on the induction of cervico-vaginal tumours in intact and castrate rats.
Topics: Animals; Benz(a)Anthracenes; Body Weight; Carcinoma; Castration; Diethylstilbestrol; Drug Synergism; | 1970 |
A review of the treatment of 222 patients with malignant tumours of the thyroid gland.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma; Carcinoma, Papillary; Child; Fem | 1970 |
The effect of sex and of sex and thyroid hormones on the induction of cancers in the salivary glands of rats.
Topics: Animals; Benz(a)Anthracenes; Carcinoma; Castration; Diethylstilbestrol; Female; Male; Methylthiourac | 1966 |